Atlas Trials

Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Clinical trial NCT02538926 · WITHDRAWN

Trial details

NCT number
NCT02538926
Sponsor
University of Washington
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
B Acute Lymphoblastic LeukemiaB Lymphoblastic LymphomaRecurrent Adult Acute Lymphoblastic LeukemiaRecurrent B Lymphoblastic LymphomaRecurrent T Lymphoblastic Leukemia/LymphomaRefractory B Lymphoblastic LymphomaRefractory T Lymphoblastic LymphomaT Acute Lymphoblastic LeukemiaT Lymphoblastic Lymphoma
Start date
2018-07-01
Primary completion
2020-07-30
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.